Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EBT (2016 - 2025)

Historic EBT for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$53.9 million.

  • Wave Life Sciences' EBT rose 1283.26% to -$53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$121.9 million, marking a year-over-year increase of 1443.41%. This contributed to the annual value of -$97.0 million for FY2024, which is 6670.91% down from last year.
  • Latest data reveals that Wave Life Sciences reported EBT of -$53.9 million as of Q3 2025, which was up 1283.26% from -$50.5 million recorded in Q2 2025.
  • Wave Life Sciences' 5-year EBT high stood at $29.3 million for Q4 2024, and its period low was -$61.8 million during Q3 2024.
  • For the 5-year period, Wave Life Sciences' EBT averaged around -$31.1 million, with its median value being -$37.8 million (2022).
  • Data for Wave Life Sciences' EBT shows a peak YoY increase of 27995.2% (in 2024) and a maximum YoY decrease of 103961.98% (in 2024) over the last 5 years.
  • Wave Life Sciences' EBT (Quarter) stood at -$35.0 million in 2021, then decreased by 22.98% to -$43.0 million in 2022, then soared by 62.22% to -$16.3 million in 2023, then surged by 279.95% to $29.3 million in 2024, then plummeted by 284.09% to -$53.9 million in 2025.
  • Its EBT was -$53.9 million in Q3 2025, compared to -$50.5 million in Q2 2025 and -$46.9 million in Q1 2025.